180 LIFE SCIENCES CORP (ATNF) Forecast, Price Target & Analyst Ratings

NASDAQ:ATNFUS68236V3024

Current stock price

7.04 USD
-0.57 (-7.49%)
At close:
7.29 USD
+0.25 (+3.55%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for 180 LIFE SCIENCES CORP (ATNF).

Forecast Snapshot

Consensus Price Target

Price Target
N/A
N/A

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 12, 2025

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
N/A
Upside
N/A
From current price of $7.04 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

Analyst Ratings & History

Current Analyst Ratings

ATNF Current Analyst RatingATNF Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

ATNF Historical Analyst RatingsATNF Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
ATNF was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ATNF.
In the previous month the buy percentage consensus was at a similar level.
ATNF was analyzed by 7 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2022-05-09Maxim GroupDowngrade Buy -> Hold
2021-09-15Maxim GroupInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 12, 2025

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

Full Analyst Estimates 2025 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
ATNF revenue by date.ATNF revenue by date.
N/AN/A
137.52%
N/A
89.26%
N/A
76.76%
N/A
54.84%
N/A
39.14%
EBITDA
YoY % growth
ATNF ebitda by date.ATNF ebitda by date.
N/AN/AN/AN/A-5.523M-15.531M
-181.22%
-17.789M
-14.54%
-13.372M
24.83%
-6.266M
53.14%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ATNF ebit by date.ATNF ebit by date.
-3.1K-343.9K
-10,993.55%
-599.1K
-74.21%
-1.209M
-101.79%
-5.648M
-367.21%
-15.641M
-176.92%
-17.898M
-14.43%
-13.478M
24.70%
-6.325M
53.07%
N/A
-69.67%
N/A
160.07%
N/A
367.55%
N/A
132.39%
N/A
69.99%
N/A
45.53%
Operating Margin
ATNF operating margin by date.ATNF operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ATNF eps by date.ATNF eps by date.
N/AN/AN/AN/AN/AN/AN/A
92.59%
N/A
73.68%
N/A
50.00%
N/AN/AN/AN/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ATNF Yearly Revenue VS EstimatesATNF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
ATNF Yearly EPS VS EstimatesATNF Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -100 -200 -300

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
90.65%
Revenue Next 5 Year
80.13%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

180 LIFE SCIENCES CORP / ATNF Forecast FAQ

When does 180 LIFE SCIENCES CORP (ATNF) report earnings?

180 LIFE SCIENCES CORP (ATNF) will report earnings on 2025-11-12.

What is the consensus rating for 180 LIFE SCIENCES CORP (ATNF) stock?

The consensus rating for 180 LIFE SCIENCES CORP (ATNF) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.